HSBC Holdings
TGTX icon

HSBC Holdings’s TG Therapeutics TGTX Stock Holding History

HSBC Holdings’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.56M Sell
106,344
-39,743
-27% -$1.18M ﹤0.01% 1286
2025
Q4 		$4.37M Buy
146,087
+101,646
+229% +$3.32M ﹤0.01% 1264
2025
Q3 		$1.61M Sell
44,441
-11,663
-21% -$384K ﹤0.01% 1595
2025
Q2 		$2.02M Buy
56,104
+43,274
+337% +$1.61M ﹤0.01% 1487
2025
Q1 		$475K Sell
12,830
-5,578
-30% -$188K ﹤0.01% 2110
2024
Q4 		$559K Sell
18,408
-26,846
-59% -$770K ﹤0.01% 2107
2024
Q3 		$1.07M Buy
45,254
+9,033
+25% +$197K ﹤0.01% 1662
2024
Q2 		$643K Buy
36,221
+17,375
+92% +$277K ﹤0.01% 1855
2024
Q1 		$287K Buy
+18,846
New +$300K ﹤0.01% 2476
2022
Q2 		– Sell
-10,080
Closed -$98K – 3444
2022
Q1 		$98K Buy
+10,080
New +$117K ﹤0.01% 3126
2021
Q4 		– Sell
-5,092
Closed -$173K – 3353
2021
Q3 		$173K Sell
5,092
-1,374
-21% -$42.5K ﹤0.01% 2810
2021
Q2 		$253K Buy
+6,466
New +$254K ﹤0.01% 2630
2020
Q1 		– Sell
-8,691
Closed -$98K – 3019
2019
Q4 		$98K Buy
+8,691
New +$66.1K ﹤0.01% 2932
2019
Q3 		– Sell
-4,629
Closed -$32.3K – 3153
2019
Q2 		$40K Sell
4,629
-3,132
-40% -$23.7K ﹤0.01% 2662
2019
Q1 		$62K Buy
+7,761
New +$41.9K ﹤0.01% 2648
2018
Q4 		– Sell
-4,125
Closed -$23K – 2716
2018
Q3 		$23K Buy
4,125
+186
+5% +$2.13K ﹤0.01% 2518
2018
Q2 		$51K Buy
+3,939
New +$54.2K ﹤0.01% 2527

Other funds holding TGTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

HSBC Holdings's TGTX Position: Q1 2026 in Review

HSBC Holdings reduced its TG Therapeutics (TGTX) stake by 27% in Q1 2026, selling an estimated $1.18M and leaving 106,344 shares worth $3.56M. The position accounts for ﹤0.01% of the portfolio, ranked #1286.

HSBC Holdings first reported a position in TGTX in Q2 2018 and has held it in 17 quarters since. The position peaked at $4.37M in Q4 2025. 363 funds tracked by Wall St. Rank hold TGTX as of Q1 2026.

  • HSBC Holdings held 106,344 shares of TG Therapeutics worth $3.56M as of Q1 2026.
  • HSBC Holdings sold 39,743 TG Therapeutics shares in Q1 2026, an estimated $1.18M.
  • TG Therapeutics made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #1286 holding.
  • HSBC Holdings first reported a position in TG Therapeutics in Q2 2018 and has held it in 17 quarters since.
  • HSBC Holdings's TG Therapeutics position peaked at $4.37M in Q4 2025.
  • 363 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.